Cargando…

Long-term clinical outcomes of COVID-19 patients treated with imatinib

Detalles Bibliográficos
Autores principales:	Duijvelaar, Erik, Schippers, Job R, Smeele, Patrick J, de Raaf, Michiel Alexander, Vanhove, Arthur L E M, Blok, Siebe G, Twisk, Jos W R, Noordegraaf, Anton Vonk, de Man, Frances S, Bogaard, Harm Jan, Aman, Jurjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853671/ https://www.ncbi.nlm.nih.gov/pubmed/35183270 http://dx.doi.org/10.1016/S2213-2600(22)00052-2

Ejemplares similares

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
por: de Brabander, Justin, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19
por: Baalbaki, Nadia, et al.
Publicado: (2023)

Pulmonary hypertension with warm hands
por: Botros, Liza, et al.
Publicado: (2017)

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
por: Atmowihardjo, Leila N., et al.
Publicado: (2023)

Neurohormonal modulation in pulmonary arterial hypertension
por: Peters, Eva L., et al.
Publicado: (2021)

A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension
por: Smits, A. Josien, et al.
Publicado: (2022)

Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
por: Bogaard, Harm Jan, et al.
Publicado: (2022)

Author's reply
por: Trip, Pia, et al.
Publicado: (2013)

Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension
por: Trip, Pia, et al.
Publicado: (2012)

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study
por: Bartelink, Imke H., et al.
Publicado: (2021)

A critical appraisal of transpulmonary and diastolic pressure gradients
por: Handoko, M. Louis, et al.
Publicado: (2016)

Nutritional status in pulmonary arterial hypertension
por: Kwant, Chermaine T., et al.
Publicado: (2022)

The UPHILL study: A nutrition and lifestyle intervention to improve quality of life for patients with pulmonary arterial hypertension
por: Kwant, Chermaine T., et al.
Publicado: (2023)

Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases
por: Spruijt, Onno A., et al.
Publicado: (2013)

Pulmonary hypertension
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2016)

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
por: Raamsteeboers, Aniek J., et al.
Publicado: (2014)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
por: Peters, Eva L., et al.
Publicado: (2021)

Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers
por: Botros, Liza, et al.
Publicado: (2021)

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
por: Atmowihardjo, Leila, et al.
Publicado: (2022)

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
por: Aman, Jurjan, et al.
Publicado: (2021)

Assembly 13: placing the pulmonary circulation in the heart of ERS
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2019)

Predicting pulmonary hypertension with standard computed tomography pulmonary angiography
por: Spruijt, Onno A., et al.
Publicado: (2015)

Uptake and Patient Perspectives on Additional Testing for Novel Disease-Associated Genes: Lessons from a PAH Cohort
por: Jansen, Samara M. A., et al.
Publicado: (2021)

Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension
por: Tio, Darryl, et al.
Publicado: (2013)

Increased native T1-values at the interventricular insertion regions of precapillary pulmonary hypertension patients
por: Spruijt, Onno A, et al.
Publicado: (2015)

Neurofilament light increases over time in severe COVID-19 and is associated with delirium
por: Smeele, Patrick J, et al.
Publicado: (2022)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: van de Bovenkamp, Arno A., et al.
Publicado: (2021)

Treatment response in patients with idiopathic pulmonary arterial hypertension and a severely reduced diffusion capacity
por: van der Bruggen, Cathelijne E., et al.
Publicado: (2017)

Prognostic Relevance of Changes in Exercise Test Variables in Pulmonary Arterial Hypertension
por: Groepenhoff, Herman, et al.
Publicado: (2013)

Pulmonary vascular remodeling and right heart failure in pulmonary hypertension: future role of positron emission tomography in decoding the enigma
por: Harms, Hendrik J, et al.
Publicado: (2013)

Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients
por: Nossent, Esther J., et al.
Publicado: (2021)

The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?
por: Wessels, Jeroen N., et al.
Publicado: (2020)

Right Atrial Pressure Affects the Interaction between Lung Mechanics and Right Ventricular Function in Spontaneously Breathing COPD Patients
por: Boerrigter, Bart, et al.
Publicado: (2012)

When right ventricular pressure meets volume: The impact of arrival time of reflected waves on right ventricle load in pulmonary arterial hypertension
por: Fukumitsu, Masafumi, et al.
Publicado: (2022)

The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS
por: Atmowihardjo, Leila N., et al.
Publicado: (2023)

Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension
por: Spruijt, Onno A., et al.
Publicado: (2015)

The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension
por: van der Bruggen, Cathelijne Emma, et al.
Publicado: (2021)

Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations
por: Llucià-Valldeperas, Aida, et al.
Publicado: (2021)

Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance
por: Rol, Nina, et al.
Publicado: (2017)

Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
por: Jujo Sanada, Takayuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l0mutjcdunkdaflgt2n842k01t